Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Merz USA names new president and CEO
Greensboro, N.C. - Jack Britts, who was previously a pharmaceutical executive at Sepracor and AstraZeneca PLC, has been named President and CEO of Merz Pharmaceuticals, according to dbusinessnews.com.
Greensboro, N.C.
- Jack Britts, who was previously a pharmaceutical executive at Sepracor and AstraZeneca PLC, has been named President and CEO of Merz Pharmaceuticals, according to
dbusinessnews.com
.
Mr. Britts will oversee the medical dermatology business, as well as establish two new product avenues in aesthetics and neurology.
Related Videos
Related Content
